David Westenberg

Q: What is David Westenberg's success rate?

David Westenberg currently has a success rate of 98.77540937323546.

Q: What is the average return of David Westenberg's calls?

Their stock ratings have generated an average return of 32.94957180295926.

Piper Sandler | Healthcare

David Westenberg is an analyst from Piper Sandler specializing in the Healthcare sector. Ranked #442 out of 4752 analysts, they have issued 50 stock ratings with a success rate of 98.78% and an average return of 32.95%.

David Westenberg has a well-established track record, with 50 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 98.78% and an average return of 32.95%, underscoring their expertise and ability to identify winning opportunities for investors.

#442

Out of 4752

Total Ratings

+98.78%

Success Rate

+32.95%

Average Return

Recent Ratings Analysis

ADPT

Buy

Aug 04, 2026

Target

$27.50

Current

$24.55

Performance

0.00%

David Westenberg rated ADPT as Overweight on Aug 04, 2026, setting a price target of 27.5. Shares have remained stable near 24.55, leaving the 27.5 target still in play.

VCYT

Buy

Aug 04, 2026

Target

$54.00

Current

$46.41

Performance

0.00%

On Aug 04, 2026, VCYT was given a Overweight rating by David Westenberg, with a target price of 54. The stock traded sideways with a 0.00% move, keeping the bullish thesis unresolved.

TEM

Hold

Aug 04, 2026

Target

$56.00

Current

$47.05

Performance

0.00%

TEM received a Neutral rating from David Westenberg on Aug 04, 2026, aiming for 56. Shares remained flat at 47.05, aligning with the neutral rating.

LH

Hold

Aug 04, 2026

Target

$309.00

Current

$312.34

Performance

0.00%

On Aug 04, 2026, David Westenberg published a Neutral outlook on LH, with a target of 309. Sideways action left the Hold view intact, with no major move since 312.34.

GH

Buy

Aug 04, 2026

Target

$193.00

Current

$159.79

Performance

0.00%

David Westenberg on Aug 04, 2026 assigned GH a Overweight rating, with a price target of 193. The recommendation remains pending validation as shares consolidate around 159.79.

FLGT

Hold

Aug 04, 2026

Target

$19.00

Current

$18.55

Performance

0.00%

On Aug 04, 2026, David Westenberg reaffirmed FLGT with a Neutral rating, targeting 19. The neutral call matched muted market action of 0.00%.

NEOG

Hold

Aug 03, 2026

Target

$13.00

Current

$11.81

Performance

-0.76%

NEOG was rated Neutral by David Westenberg on Aug 03, 2026, with a price objective of 13. Flat performance suggests the Hold view was reasonable.

ILMN

Buy

Aug 03, 2026

Target

$225.00

Current

$203.01

Performance

2.45%

On Aug 03, 2026, David Westenberg initiated coverage on ILMN with a Overweight rating and target of 225. Neutral price movement of 2.45% leaves room for interpretation.

TMO

Hold

Jul 27, 2026

Target

$600.00

Current

$564.75

Performance

0.93%

David Westenberg issued a Neutral recommendation for TMO on Jul 27, 2026, price target set at 600. The rating was appropriate for a consolidating market trading near 564.75.

TXG

Hold

Jul 01, 2026

Target

$42.00

Current

$47.86

Performance

22.56%

On Jul 01, 2026, TXG was evaluated by David Westenberg, who gave a Neutral rating and target of 42. Investors who stayed in despite the Hold saw upside of 22.56%.

WGS

Buy

Jun 23, 2026

Target

$63.00

Current

$70.90

Performance

22.07%

David Westenberg rated WGS as Overweight on Jun 23, 2026, setting a price target of 63. The call has proven timely, with shares rising 22.07% toward the price target of 63.

DHR

Hold

Jun 11, 2026

Target

$200.00

Current

$194.78

Performance

7.74%

On Jun 11, 2026, DHR was given a Neutral rating by David Westenberg, with a target price of 200. The stock rallied from 194.78 to 194.78 after the Hold rating, surprising to the upside.

A

Hold

Jun 11, 2026

Target

$150.00

Current

$139.20

Performance

7.45%

A received a Neutral rating from David Westenberg on Jun 11, 2026, aiming for 150. Investors saw gains of 7.45% that the cautious stance didn’t fully capture.

TECH

Hold

Jun 11, 2026

Target

$65.00

Current

$72.09

Performance

33.45%

On Jun 11, 2026, David Westenberg published a Neutral outlook on TECH, with a target of 65. The Hold call missed some of the bullish momentum as shares advanced toward 65.

TWST

Buy

Jun 11, 2026

Target

$85.00

Current

$99.44

Performance

34.29%

David Westenberg on Jun 11, 2026 assigned TWST a Overweight rating, with a price target of 85. The Buy call aligned well with market performance, producing a gain of 34.29%.

WAT

Hold

Jun 11, 2026

Target

$400.00

Current

$396.08

Performance

10.10%

On Jun 11, 2026, David Westenberg reaffirmed WAT with a Neutral rating, targeting 400. Market strength beyond 396.08 went further than the conservative outlook suggested.

GRAL

Hold

May 06, 2026

Target

$56.00

Current

$72.70

Performance

15.86%

GRAL was rated Neutral by David Westenberg on May 06, 2026, with a price objective of 56. Despite caution, upside momentum rewarded risk-takers with gains to 72.7.

CAI

Hold

Apr 10, 2026

Target

$21.00

Current

$16.10

Performance

-10.80%

On Apr 10, 2026, David Westenberg initiated coverage on CAI with a Neutral rating and target of 21. The rating matched the stock’s inability to hold above 16.1.

NEO

Buy

Feb 24, 2026

Target

$13.00

Current

$16.29

Performance

68.81%

David Westenberg issued a Overweight recommendation for NEO on Feb 24, 2026, price target set at 13. Investors following the Buy call captured upside momentum, with shares now at 16.29.

IDXX

Hold

Feb 09, 2026

Target

$750.00

Current

$588.09

Performance

-8.08%

On Feb 09, 2026, IDXX was evaluated by David Westenberg, who gave a Neutral rating and target of 750. The Hold call avoided chasing into subsequent weakness of 8.08%.

ZTS

Hold

Jan 22, 2026

Target

$135.00

Current

$76.01

Performance

-38.90%

David Westenberg rated ZTS as Neutral on Jan 22, 2026, setting a price target of 135. The cautious Hold call aligned with subsequent weakness, as shares slipped 38.90%.

ELAN

Buy

Jan 22, 2026

Target

$30.00

Current

$25.58

Performance

2.69%

On Jan 22, 2026, ELAN was given a Overweight rating by David Westenberg, with a target price of 30. The stock traded sideways with a 2.69% move, keeping the bullish thesis unresolved.

BLLN

Buy

Dec 01, 2025

Target

$150.00

Current

$142.25

Performance

25.84%

BLLN received a Overweight rating from David Westenberg on Dec 01, 2025, aiming for 150. Momentum has favored the Buy call, with shares climbing from 142.25 to 142.25, rewarding those who trusted the recommendation.

EXAS

Buy

Nov 11, 2025

Target

$80.00

Current

$104.91

Performance

55.42%

On Nov 11, 2025, David Westenberg published a Overweight outlook on EXAS, with a target of 80. Shares gained 55.42%, underscoring the accuracy of the bullish outlook toward 80.

PACB

Hold

Nov 11, 2025

Target

$2.00

Current

$1.44

Performance

-22.58%

David Westenberg on Nov 11, 2025 assigned PACB a Neutral rating, with a price target of 2. The call successfully avoided chasing as shares lost 22.58%.

NTRA

Buy

Nov 11, 2025

Target

$230.00

Current

$275.19

Performance

33.12%

On Nov 11, 2025, David Westenberg reaffirmed NTRA with a Overweight rating, targeting 230. The recommendation was supported by strong follow-through as the stock rose from 275.19 to 275.19.

CTKB

Buy

Nov 11, 2025

Target

$7.50

Current

$4.28

Performance

-10.65%

CTKB was rated Overweight by David Westenberg on Nov 11, 2025, with a price objective of 7.5. This case shows how bullish projections can fail, with the stock now below 4.28.

DGX

Hold

Oct 27, 2025

Target

$200.00

Current

$233.72

Performance

29.66%

On Oct 27, 2025, David Westenberg initiated coverage on DGX with a Neutral rating and target of 200. The Hold stance underestimated the stock’s strength as it gained 29.66%.

AKYA

Buy

Nov 19, 2024

Target

$3.00

Current

$1.29

Performance

-40.28%

David Westenberg issued a Overweight recommendation for AKYA on Nov 19, 2024, price target set at 3. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

Frequency Asked Questions

Who is David Westenberg?

David Westenberg is an analyst from Piper Sandler specializing in the Healthcare sector.

What is David Westenberg's success rate?

David Westenberg currently has a success rate of +98.78%.

How many ratings has David Westenberg issued?

David Westenberg has issued 50 stock ratings so far.

What is the average return of David Westenberg's calls?

Their stock ratings have generated an average return of +32.95%.

What is David Westenberg's ranking?

David Westenberg is ranked #442 out of 4752 analysts.

What types of ratings does David Westenberg give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow David Westenberg?

You can follow David Westenberg by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by David Westenberg?

Their latest rating was a Buy on ADPT issued on 2026-08-04.